Robin Michelet

About Robin Michelet

Robin Michelet, With an exceptional h-index of 12 and a recent h-index of 12 (since 2020), a distinguished researcher at Freie Universität Berlin, specializes in the field of Pharmacometrics, PBPK, pharmacology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Bayesian framework for multi-source data integration-Application to human extrapolation from preclinical studies

Nonlinear Mixed‐Effects Model of Z‐Endoxifen Concentrations in Tamoxifen‐Treated Patients from the CEPAM Cohort

Inhalation of an immunomodulatory adjuvant to treat drug-resistant bacterial pneumonia

C-Reactive Protein as an Early Predictor of Efficacy in Advanced Non-Small-Cell Lung Cancer Patients: A Tumor Dynamics-Biomarker Modeling Framework

Towards Model-Informed Precision Dosing of Voriconazole: Challenging Published Voriconazole Nonlinear Mixed-Effects Models with Real-World Clinical Data

Barriers to global pharmacometrics: educational challenges and opportunities across the globe

Model-Informed Target Morning 17α-Hydroxyprogesterone Concentrations in Dried Blood Spots for Pediatric Congenital Adrenal Hyperplasia Patients

Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach

Robin Michelet Information

University

Position

Senior scientist

Citations(all)

658

Citations(since 2020)

616

Cited By

137

hIndex(all)

12

hIndex(since 2020)

12

i10Index(all)

18

i10Index(since 2020)

18

Email

University Profile Page

Google Scholar

Robin Michelet Skills & Research Interests

Pharmacometrics

PBPK

pharmacology

Top articles of Robin Michelet

Bayesian framework for multi-source data integration-Application to human extrapolation from preclinical studies

Statistical Methods in Medical Research

2024/4

Robin Michelet
Robin Michelet

H-Index: 6

Nonlinear Mixed‐Effects Model of Z‐Endoxifen Concentrations in Tamoxifen‐Treated Patients from the CEPAM Cohort

Clinical Pharmacology & Therapeutics

2024/3/18

Inhalation of an immunomodulatory adjuvant to treat drug-resistant bacterial pneumonia

Revue des Maladies Respiratoires

2024/3/1

C-Reactive Protein as an Early Predictor of Efficacy in Advanced Non-Small-Cell Lung Cancer Patients: A Tumor Dynamics-Biomarker Modeling Framework

Cancers

2023/11/15

Robin Michelet
Robin Michelet

H-Index: 6

Towards Model-Informed Precision Dosing of Voriconazole: Challenging Published Voriconazole Nonlinear Mixed-Effects Models with Real-World Clinical Data

Clinical Pharmacokinetics

2023/10

Robin Michelet
Robin Michelet

H-Index: 6

Barriers to global pharmacometrics: educational challenges and opportunities across the globe

2023/6

Model-Informed Target Morning 17α-Hydroxyprogesterone Concentrations in Dried Blood Spots for Pediatric Congenital Adrenal Hyperplasia Patients

Pharmaceuticals

2023/3/21

Robin Michelet
Robin Michelet

H-Index: 6

Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach

Frontiers in Pharmacology

2023/1/12

Robin Michelet
Robin Michelet

H-Index: 6

Microdialysis of Voriconazole and its N-Oxide Metabolite: Amalgamating Knowledge of Distribution and Metabolism Processes in Humans

Pharmaceutical Research

2022/12

Robin Michelet
Robin Michelet

H-Index: 6

Quantification of the time course of CYP3A inhibition, activation, and induction using a population pharmacokinetic model of microdosed midazolam continuous infusion

Clinical Pharmacokinetics

2022/11

Robin Michelet
Robin Michelet

H-Index: 6

Microdialysis of drug and drug metabolite: a comprehensive in vitro analysis for voriconazole and voriconazole N-oxide

Pharmaceutical Research

2022/11

Robin Michelet
Robin Michelet

H-Index: 6

Ulcerative colitis and acute severe ulcerative colitis patients are overlooked in infliximab population pharmacokinetic models: results from a comprehensive review

2022/9/30

Robin Michelet
Robin Michelet

H-Index: 6

The Impact of Low Cardiac Output on Propofol Pharmacokinetics across Age Groups—An Investigation Using Physiologically Based Pharmacokinetic Modelling

Pharmaceutics

2022/9/16

High-dosage fosfomycin results in adequate plasma and target-site exposure in morbidly obese and nonobese nonhyperfiltration patients

Antimicrobial Agents and Chemotherapy

2022/6/21

Evaluation of a meropenem and piperacillin monitoring program in intensive care unit patients calls for the regular assessment of empirical targets and easy-to-use dosing …

Antibiotics

2022/6/2

Franz Weber
Franz Weber

H-Index: 8

Robin Michelet
Robin Michelet

H-Index: 6

Comparative plasma and interstitial tissue fluid pharmacokinetics of meropenem demonstrate the need for increasing dose and infusion duration in obese and non-obese patients

Clinical Pharmacokinetics

2022/5

Exploring dried blood spot cortisol concentrations as an alternative for monitoring pediatric adrenal insufficiency patients: A model-based analysis

Frontiers in Pharmacology

2022/3/17

Robin Michelet
Robin Michelet

H-Index: 6

Towards the elucidation of the pharmacokinetics of voriconazole: a quantitative characterization of its metabolism

Pharmaceutics

2022/2/22

Robin Michelet
Robin Michelet

H-Index: 6

A versatile high-performance LC-MS/MS assay for the quantification of voriconazole and its N-oxide metabolite in small sample volumes of multiple human matrices for biomedical …

Journal of Pharmaceutical and Biomedical Analysis

2022/2/20

Robin Michelet
Robin Michelet

H-Index: 6

Combination of pharmacokinetic and pathogen susceptibility information to optimize meropenem treatment of gram-negative infections in critically Ill patients

Antimicrobial Agents and Chemotherapy

2022/2/15

Robin Michelet
Robin Michelet

H-Index: 6

See List of Professors in Robin Michelet University(Freie Universität Berlin)

Co-Authors

academic-engine